| Rosemarie Soriano-luna, CRNA | |
|
5645 Main St, Flushing, NY 11355-5045 | |
| (718) 670-1435 | |
| Not Available |
| Full Name | Rosemarie Soriano-luna |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 5645 Main St, Flushing, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942339668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 386563-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosemarie Soriano-luna, CRNA 255 W Michigan Ave, P. O. Box 1123, Jackson, MI 49201-2218 Ph: (866) 570-0077 | Rosemarie Soriano-luna, CRNA 5645 Main St, Flushing, NY 11355-5045 Ph: (718) 670-1435 |
News Archive
Biomedical engineers at the Tufts University School of Engineering have developed tiny lipid-based nanoparticles that incorporate neurotranmitters to help carry drugs, large molecules, and even gene editing proteins across the blood-brain barrier and into the brain in mice.
Family caregivers usually are not asked by health care workers about needing support in managing older adults' care, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
In the framework of this year's round of the European Research Council's (ERC) competition for outstanding researchers, Heidelberg University has totted up a remarkable score.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
Compared with non-Hispanic whites, non-Hispanic blacks and Hispanics who qualify for cholesterol-lowering drug treatment are less likely to have their "bad" LDL cholesterol controlled to recommended levels, researchers reported at the American Heart Association's Scientific Sessions 2004.
› Verified 2 days ago
Sonia A Tenadu, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1435 | |
Crisalind Canga, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1435 | |
Hao Tran, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 56-45 Main Street, Flushing, NY 11355 Phone: 718-670-2000 | |
Amanda C Wagner, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-2000 | |
Marlene Ngo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1435 | |
Debra Kay Duhart-ball, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1435 | |
Maria Unni, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-1435 |